Cullinan Therapeutics, Inc.
CGEMNasdaqCIK 1789972HealthcareFiscal year ends Dec 31
Reports and events: 105 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-01-1316:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-008134 |
| 2021-01-0616:47 ET | S-1/A | Registration statement, amended | 0001193125-21-003224 |
| 2021-01-0406:12 ET | S-1/A | Registration statement, amended | 0001193125-21-000161 |
| 2020-12-2808:57 ET | S-1/A | Registration statement, amended | 0001193125-20-326964 |
| 2020-12-1817:16 ET | S-1 | Registration statement | 0001193125-20-321670 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:50 ET. Listed shows no prices and gives no investment advice.